ThursdayMar 17, 2022 2:14 pm

Study Discovers Link Between Metabolism, the Circadian Rhythm

New research on addiction conducted by scientists from the University of California-Irvine has discovered links between metabolism and the circadian rhythm. The circadian clock relies on various interactions between systems to maintain regular timing and is entwined with metabolism. Environmental and/or genetic changes can distort communication between organs, which modifies the rhythm of various activities. Professor Emiliana Borrelli, the study’s author, stated that the group’s discovery showed a connection between metabolic dysfunction and substance-use disorders. Borrelli, who has specialized in molecular genetics and microbiology, collaborated with the late Professor Paolo Sassone-Corsi on this study. Substance-use disorders affect millions of individuals…

Continue Reading

ThursdayMar 17, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as Public Support Grows

More than 60% of American who suffer from mental health conditions want access to psychedelic options Growing number of cities, states looking at decriminalizing use of psychedelic medicine Cybin is working with world-class partners, internationally recognized scientists to create safe, effective therapeutics in the mental-health space The awareness of psychedelics and the potential for treating an array of mental health diseases is growing, as evidenced by a recent survey reporting that 65% of affected Americans want access to psychedelics for potential treatment (https://ibn.fm/jIV2K). Those are numbers that Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, is paying close attention…

Continue Reading

ThursdayMar 17, 2022 9:00 am

Metabolic Health Diseases Rising Globally, Nemaura Medical Inc. (NASDAQ: NMRD) Aims to Disrupt Market with Non-Invasive, Cost-Effective IoT Devices, Mikobo Coaching Program

Metabolic disease cases rising globally, diseases include diabetes, dementia, cardiovascular conditions, stroke Companies in diagnostic space posting record revenues, double-digit YOY increases Nemaura Medical aims to disrupt the market with Mikobo program’s non-invasive sensor technology, companion mobile application and coaching programs Competitor devices use microneedles coated with enzymes and polymers that can cause discomfort, trauma, and skin changes Clinical research reveals that volatile blood sugar fluctuations are a primary risk factor for rapidly rising cases of metabolic syndrome - a cluster of diseases that include diabetes, dementia, cardiovascular issues, and stroke. Abbott (NYSE: ABT), a global healthcare company targeting the…

Continue Reading

WednesdayMar 16, 2022 1:18 pm

Researchers Give Recommendations on How to Improve Diagnosis, Treatment of Prediabetes

Prediabetes is a condition that occurs when an individual’s blood sugar levels aren’t high enough to meet the type 2 diabetes threshold but are still higher than normal. Experts believe that when the condition is diagnosed while in its early stages, regular exercise and changes to an individual’s lifestyle may delay or prevent the development of type 2 diabetes as well as the heightened risks the disease poses for kidney failure, stroke, heart disease and nerve damage. However, it is unlikely that people in the United States with prediabetes are being diagnosed and treated in the early stages to prevent…

Continue Reading

TuesdayMar 15, 2022 2:18 pm

Study Finds That Gender May Predict Likelihood of Dying from CNS Cancer

A new study has found that young men have a heightened risk of death from central nervous system cancer regardless of the cancer treatment they undergo. Central nervous system cancer is one of the top five cancers diagnosed in young adults. It develops when abnormal cells form in the tissues of an individual’s spinal cord and/or brain. The presence of some genetic syndromes also increases the risk of an individual being diagnosed with a central nervous system tumor. There are different types of spinal cord and brain tumors, including germ cell tumors, meningeal tumors, pineal parenchymal tumors, medulloblastomas, ependymal tumors,…

Continue Reading

MondayMar 14, 2022 1:47 pm

Analysis Finds Disparities in Global Treatment Rates for Depression

A recently conducted analysis of various studies has found that the rates of treatment for major depressive disorder are still low across the globe, especially for individuals living in lower-middle income and low-income countries. These findings were published in “PLOS Medicine” by University of Washington’s Modhurima Moitra and University of Queensland’s Alize Ferrari along with several colleagues. In the last few years, global and national initiatives have been making efforts to address the enormous burden caused by major depressive disorder. Despite this, rates of treatment are still low. Analyses that merge results from research on treatments for depression from varying…

Continue Reading

FridayMar 11, 2022 12:49 pm

Decisive Actions the Biden Administration Plans to Take to Combat Addiction and the Overdose Crisis

The numbers of individuals succumbing to drug overdoses has increased significantly these last few years, which has left many communities and families devastated. Figures show that between September 2020 and September 2021, more than 104,000 individuals in America died due to drug overdoses. President Joseph Biden recently revealed the actions that his administration would take to address this epidemic caused by addiction, laying out a vision for how the administration would expand harm reduction, evidence-based prevention, supply reduction, recovery and treatment approaches in an attempt to save lives. These decisive actions include: Putting an end to illicit drug trafficking Cross-border…

Continue Reading

FridayMar 11, 2022 10:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Reports Positive Pre-IND Meeting with FDA, Changes to Its Clinical Trial Approach; Plans Breakthrough Therapy Designation Request for MYCO-001

Mydecine recently reported a positive Pre-IND meeting with the FDA for the MYCO-001 smoking cessation study According to the Center for Disease Control (“CDC”), tobacco is the leading cause of preventable deaths in the U.S. Following the FDA meeting, the company now intends to perform a Phase 2b study and then a Phase 3 study instead of a seamless Phase 2/3 clinical trial Mydecine plans to submit a request for breakthrough therapy status with its IND submission Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has continually taken steps toward fulfilling its mission to become a trusted source of safe and…

Continue Reading

ThursdayMar 10, 2022 11:49 am

Studies Find That Digital Health Tech Is Effective in Combating Chronic Illnesses

A study coauthored by Stanford Healthcare and Included Health that was looking into the efficacy of digital tools in managing chronic ailments has found that telehealth services have had a net positive impact on patients with hypertension. While digital health may be relatively new, the coronavirus pandemic was a game-changer for the field. With millions of people in locked-down areas and hospitals filling with coronavirus patients, a lot of people could not receive in-person medical care. However, thanks to digital tools such as phone calls and video calls, people battling chronic ailments were still able to stay up-to-date with their treatments.…

Continue Reading

WednesdayMar 09, 2022 12:54 pm

Researchers Discover Disordered Alcohol Use Leads to Poor Functional Brain Connectivity

A recently published study has found that modified neural activity patterns may compromise the ability of some individuals to interpret facial expressions. The researchers found that individuals predisposed to alcohol problems and heavy drinking may have altered signaling patterns in regions of the brain that process social situations and emotions. In their report, the researchers explained that differences in brain connectivity could help forecast future alcohol use for an individual as well as offer the basis for new interventions for the prevention and treatment of alcohol use disorder. The risk of developing alcohol use problems has been linked to a…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050